Shrimps Disease Diagnostics Market Analysis Report - 2035

Future Market Insights

Shrimps Disease Diagnostics Market

Key Insight

The shrimps disease diagnostics market is projected to grow from USD 268.4 million in 2025 to USD 783.0 million by 2035, at a CAGR of 11.3%. WSSV will dominate with a 31.8% market share, while fisheries will lead the application segment with a 42.6% share.

July 23, 2025

Anurag Sharma

250 Pages

Cite this Report

Shrimps Disease Diagnostics Market

https://www.futuremarketinsights.com/reports/shrimps-disease-diagnostics-market

License

Buy Now

Summary ToC Companies

Key Players

AquaBounty Technologies
FUJIKURA KASEI CO
GeneReach Biotechnology Corp
LAB Holdings
REAGEN LLC
SUREBIO
Speedy Assay Sdn Bhd
Thermo Fisher Scientific Inc.

Methodology

Member of

Greater New York Chamber of Commerce

Recognized by

Awarded by

SILVER STEVIE® WINNER

Asia Pacific Stevie Awards - 2023

BRONZE STEVIE® Award

20th annual IBAs

Quick Contact

Chat on Whatsapp + 44 20 3769 9709 + 1 347 918 3531 Contact By Email

Get Free Sample PDF

Shrimps Disease Diagnostics Market

Key Players

Similar Industry Reports